CT-2103 (PG-TXL): Began Phase II trials

Cell Therapeutics Inc. (CTIC), Seattle, Wash. Product: CT-2103 ( PG-TXL) Business: Cancer Therapeutic category: Cytotoxic Target: Spindle microtubules Description: Polyglutamate polymer formulation o...